Showing results (1231-1240 of 3,493) with videos related to
Sort By:
Pageof 350
Archiv Der Pharmazie|October 21, 2024
Targeting STAT3, FOXO3a, and Pim-1 kinase by FDA-approved tyrosine kinase inhibitor-Radotinib: An in silico and in vitro approachSuryaa Manoharan, Aksayakeerthana Santhakumar, Ekambaram PerumalArchiv Der Pharmazie|September 21, 2024
iNOS/PGE2 inhibitors as a novel template for analgesic/anti-inflammatory activity: Design, synthesis, in vitro biological activity and docking studiesAyca Erdogan, Yagmur Ozhan, Hande Sipahi, et al.Archiv Der Pharmazie|September 16, 2024
Multispectral investigation of natural resinsLara Heidrich, Bastian Brand, Stefan Brackmann, et al.Archiv Der Pharmazie|September 18, 2024
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cellsFrancesco Berluti, Fady Baselious, Sven Hagemann, et al.Archiv Der Pharmazie|September 13, 2024
In vitro assessment of skin permeation properties of enzymatically derived oil-based fatty acid esters of vitamin CMarija Ćorović, Milica Veljković, Ana Milivojević, et al.Archiv Der Pharmazie|October 28, 2024
Multi-functional tyrosinase inhibitors derived from kojic acid and hydroquinone-like diphenols for treatment of hyperpigmentation: Synthesis and in vitro biological evaluationMorteza Ashooriha, Mehdi Khoshneviszadeh, Maryam Kabiri, et al.Archiv Der Pharmazie|August 1, 2024
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR-2 and EGFRT790M: Molecular docking, ADMET, design, and synthesesMarwa Alsulaimany, Sanadelaslam S A El-Hddad, Zuhir S M Akrim, et al.Archiv Der Pharmazie|July 29, 2024
Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?José S Rodríguez-Zavala, Cecilia ZazuetaArchiv Der Pharmazie|July 30, 2024
Mono- and bis(steroids) containing a cyclooctane core: Synthesis, antiproliferative activity, and action on cell cytoskeleton microtubulesOlga V Ryzhikova, Aleksandra S Churkina, Kseniya N Sedenkova, et al.Archiv Der Pharmazie|June 29, 2024
Current scenario of pyrazole hybrids with anti-breast cancer therapeutic applicationsMengyu MaPageof 350